InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 03/15/2019 9:40:42 AM

Friday, March 15, 2019 9:40:42 AM

Post# of 261
News: $RHHBY European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease

F. Hoffmann-La Roche Ltd / European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. MabThera is the first biologic treatment approve...

Find out more https://marketwirenews.com/news-releases/european-commission-approves-roche-s-mabthera-rituximab-for-a-rare-autoimmune-disease-7849026.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RHHBY News